Li Xuechuan, Zhu Hongyi, Xu Peipei, Zhang Jie, Wang Zhe, He Hui, Shen Fang, Jiang Yi, Shen Lijuan, Xiang Jing, Yang Linhua, Yang Chao, Jiang Hao, Gao Ganglong, Jin Junshuo, Shen Huojian, Wang Yinping, Wu Linshi, Qian Changlin, Liu Dejun, Qiu Weiqing, Li Qiwei, Chen Yuanwen, Lin Fujun, Liu Yun
Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Tilcure Biotherapeutics, Shanghai, China.
Front Immunol. 2024 Dec 17;15:1486352. doi: 10.3389/fimmu.2024.1486352. eCollection 2024.
The coronavirus disease 2019 (COVID-19) global pandemic has been the most severe public health emergency since 2019. Currently, the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the most dominant. The most prominent symptom of SARS-CoV-2 infection is respiratory. Meanwhile, the fatality of COVID-19 was mainly from pneumonia. However ,in patients with SARS-CoV-2 infection who have pneumonia and those who do not, the differences in the immune repertoire still require further investigation.
We conducted seven-chain adaptome immune repertoire analyses on patients with SARS-CoV-2 Omicron infection, both with and without pulmonary infiltration.
Patients with pulmonary infiltration exhibit lymphopenia, a decreased proportion of the overall TCR repertoire alongside an increased BCR repertoire, reduced IGHD and IGHM isotype expression, a shorter mean CDR3 length for TRG, and a longer mean length for TRD, as well as diminished clonality and diversity in the TCR/BCR repertoire. Meanwhile, patients with pulmonary infiltration have distinct V-J gene usage and unique CDR3 signature, as well as BCR class switch recombination pattern. Finally, prior vaccination triggered less BCR IGHM/IGHD somatic hypermutation response, preserved the diversity of the entire adaptive immune repertoire, and provided clinical protection against severe or critical conditions following Omicron infection.
We report a unique, comprehensive adaptive immune system signature in patients with pulmonary infiltration, which may serve as potential immunological biomarkers and therapeutic targets.
2019年冠状病毒病(COVID-19)全球大流行是自2019年以来最严重的突发公共卫生事件。目前,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变异株最为流行。SARS-CoV-2感染最突出的症状是呼吸道症状。同时,COVID-19的死亡主要源于肺炎。然而,在感染SARS-CoV-2且患有肺炎的患者与未患肺炎的患者中,免疫组库的差异仍需进一步研究。
我们对感染SARS-CoV-2奥密克戎变异株且有或无肺部浸润的患者进行了七链适配体免疫组库分析。
有肺部浸润的患者表现出淋巴细胞减少,总体TCR组库比例降低,同时BCR组库增加,IGHD和IGHM同种型表达减少,TRG的平均CDR3长度缩短,TRD的平均长度延长,以及TCR/BCR组库中的克隆性和多样性降低。同时,有肺部浸润的患者具有独特的V-J基因使用情况、独特的CDR3特征以及BCR类别转换重组模式。最后,先前接种疫苗引发的BCR IGHM/IGHD体细胞超突变反应较少,保留了整个适应性免疫组库的多样性,并为奥密克戎感染后的严重或危重症提供了临床保护。
我们报告了有肺部浸润患者独特、全面的适应性免疫系统特征,这可能作为潜在的免疫生物标志物和治疗靶点。